Expression of GP88 (progranulin) in serum of prostate cancer patients is associated with Gleason scores and overall survival

BACKGROUND: GP88/Progranulin is a well-recognized cell growth promoter in different cancers, and elevated serum GP88 levels have been described as negative prognostic factor in breast cancer. However, serum levels in prostate cancer (PCa) patients have not yet been studied. MATERIAL AND METHODS: We...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Manag Res
Hlavní autoři: Greither, Thomas, Fischer, Kersten, Theil, Gerit, Marcou, Marios, Holzhausen, Hans-Juergen, Weigelt, Katrin, Serrero, Ginette, Hicks, David, Yue, Binbin, Fornara, Paolo, Wullich, Bernd, Taubert, Helge, Wach, Sven, Lieb, Verena
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6178934/
https://ncbi.nlm.nih.gov/pubmed/30323673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S172069
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky